New Research on PMDD Subtypes: Why Your Pattern May Not Look Like Someone Else’s

PMDD is often discussed as if everyone has the same “bad week before a period.” New research suggests the reality is more individual: symptoms can begin at different times, last for different lengths, clear at different speeds, and respond differently to ovarian hormones.

Important: PMDD is a serious, treatable mental-health condition linked to the menstrual cycle. If you have suicidal thoughts, feel unsafe, or fear you may harm yourself, seek urgent local emergency or mental-health support immediately.

What is PMDD?

Premenstrual dysphoric disorder (PMDD) is a cyclical condition in which severe emotional and physical symptoms occur in the luteal phase, after ovulation and before menstruation, then substantially improve after the period begins. Diagnosis requires prospective daily symptom tracking across at least two cycles, because a calendar-based pattern—not symptoms alone—is central to identifying PMDD.

PMDD is not caused by “abnormal” hormone levels in the usual sense. A key scientific theory is that some people have an unusually sensitive brain-and-body response to normal shifts in ovarian steroids such as estradiol and progesterone.

Why are PMDD subtypes being studied?

Not everyone with clinically confirmed PMDD has symptoms on the same days or in the same form. Some people feel unwell mainly in the final premenstrual week, while others notice symptoms soon after ovulation and struggle for roughly two weeks. Others find that anxiety or depression does not lift immediately when bleeding starts.

This matters because a single treatment pathway may not work equally well for every person. Eisenlohr-Moul’s 2025 professional commentary argues for precision reproductive psychiatry: a targeted, transdiagnostic approach that looks beyond one diagnostic label and considers each person’s timing, symptom profile, hormone sensitivity, co-occurring conditions, and treatment response.

What did the 2020 study find about temporal PMDD subtypes?

In a 2020 Psychological Medicine study, Eisenlohr-Moul and colleagues used group-based trajectory modelling to examine how PMDD symptoms changed across the cycle. This method looks at daily symptom data and identifies recurring patterns, rather than assuming that all participants follow one average curve.

The study included 74 people with prospectively confirmed DSM-5 PMDD and tracked symptoms from approximately 14 days before menstruation through nine days after menstrual onset.

Which three overall patterns were found?

For total daily PMDD symptoms, the best-fitting model identified three temporal patterns:

These patterns are promising research findings, not yet separate official PMDD diagnoses. They need replication in larger, more diverse samples and research testing whether they reliably predict biology or treatment response.

What does “full luteal phase PMDD” mean?

The full-luteal-phase pattern describes symptoms that begin close to ovulation and continue until menstruation starts. In practical terms, this may mean around 12 to 14 symptomatic days each cycle, rather than only a few difficult days before bleeding.

The researchers proposed that an earlier-onset pattern could reflect sensitivity to hormonal and neurosteroid changes soon after ovulation. They also noted that this group may be especially relevant to research on treatments that suppress ovarian cycling, but this is a hypothesis—not a reason to self-select a medical treatment.

What might this look like in real life?

You may notice:

• “I feel emotionally different almost immediately after ovulation.”

• Irritability, anxiety, or low mood that builds through the entire second half of the cycle

• A relatively clear “good” follicular phase after symptoms settle

• A consistent pattern that is visible only when you track daily, not when you look back from memory

What does “late-offset PMDD” mean?

A late-offset pattern means symptoms do not switch off immediately when bleeding begins. Instead, low mood, anxiety, exhaustion, or emotional vulnerability may take several days to ease during menstruation or early follicular days.

In the 2020 study, late offset appeared not only for sadness but also for anxiety and the overall symptom score. The authors discussed possible roles for factors such as rumination, past depression, and emotion-regulation difficulties, alongside biological sensitivity.

This does not automatically mean someone does not have PMDD. But it does make careful assessment important, because clinicians may need to distinguish PMDD from:

• Premenstrual exacerbation (PME): an existing condition, such as depression, anxiety, OCD, ADHD, or bipolar disorder, that worsens premenstrually but remains present at other points in the cycle

• A depressive or anxiety disorder that needs treatment throughout the month

• A mixed pattern in which PMDD and another condition coexist

Do different PMDD symptoms follow different timelines?

Yes. One important finding is that a person may not have one neat, single subtype across every symptom. For example, irritability may start after ovulation, while sadness may appear later but take longer to resolve after a period begins.

The 2020 study found different trajectory groups for individual symptoms:

This is why tracking individual symptoms separately is more useful than only rating “PMDD severity” once a day.

What did the 2025 ovarian-hormone study show?

Wei and colleagues published a replication and extension study in the American Journal of Psychiatry in 2025. It tested whether PMDD symptoms changed when ovarian hormone cycling was medically suppressed and then estradiol or progesterone was added back separately.

The study included 34 women with PMDD and 76 healthy comparison participants. Participants completed daily ratings during three conditions:

1. Leuprolide alone, which suppresses ovarian cycling

2. Leuprolide plus estradiol add-back

3. Leuprolide plus progesterone add-back

What were the key findings?

The study found that:

• Ovarian suppression eliminated the cyclical symptom pattern in participants with PMDD.

• Adding back estradiol or progesterone increased affective symptoms—anxiety, sadness, irritability, and mood swings—in the PMDD group compared with suppression alone.

• Healthy comparison participants did not show the same PMDD symptom response to the same hormone add-back conditions.

• Irritability and mood swings were more closely linked to progesterone add-back than estradiol add-back in PMDD.

• Bloating and food cravings were more severe in the PMDD group regardless of hormone condition, while breast pain increased more during estradiol add-back.

Does this mean progesterone causes PMDD?

Not exactly. The study supports the idea that PMDD involves an altered response to normal ovarian steroids, rather than simply having “too much progesterone” or “too much estrogen.”

It is also not evidence that progesterone is harmful for every person with PMDD, or that everyone should avoid hormonal treatment. Hormonal interventions can have very different effects between individuals, and decisions should be made with a qualified gynaecologist, psychiatrist, or reproductive mental-health clinician.

How do the 2020 and 2025 studies fit together?

Together, these studies suggest that PMDD may involve more than one clinically meaningful pathway.

What does precision reproductive psychiatry mean?

Precision reproductive psychiatry is an emerging approach that aims to match care more closely to a person’s real symptom pattern rather than treating all menstrual-cycle-related mood symptoms as identical. Eisenlohr-Moul’s 2025 article calls for research and clinical approaches that are both targeted and transdiagnostic.

“Transdiagnostic” means looking beyond labels alone. Someone may have PMDD alongside anxiety, ADHD, OCD, trauma-related symptoms, depression, sleep problems, or postpartum mood vulnerability. Their care may need to address both the cyclical hormonal pattern and the ongoing mental-health condition. Comorbidity in this situation is crucial to take underconsideration.

A precision approach may eventually include:

• Daily symptom timing and symptom-specific tracking

• Ovulation and period dates

• Baseline symptoms outside the luteal phase

• Mental-health history and current diagnoses

• Sensitivity to hormonal contraception or past hormone treatments

• Sleep, stress, food, pain, medication, and life-event patterns

• A collaborative treatment plan reviewed over several cycles.

How can you track your PMDD pattern accurately?

Daily tracking is the most practical first step. It can turn “I feel terrible before my period” into information a clinician can use: which symptoms, on which days, how severe, how long they last, and how much they affect functioning.

What should you track each day?

Use a 0 to 3, 0 to 5, or 0 to 10 scale and record:

• Period start and end dates

• Possible ovulation signs, if you track them

• Irritability or anger

• Anxiety and feeling overwhelmed

• Sadness, hopelessness, or crying spells

• Mood swings and sensitivity to rejection

• Sleep quality and nightmares

• Energy, concentration, and food cravings

• Bloating, breast tenderness, cramps, headaches, and body pain

• Conflict, work or study impact, and social withdrawal

• Thoughts of self-harm or suicide, so you can discuss urgent risk and safety planning with a clinician

Use HealCycle for a brief daily check-in—not just when symptoms become unbearable. Track your mood, physical symptoms, sleep, functioning, and cycle dates through at least two cycles.

Look for answers to questions such as:

• Do symptoms begin just before your period, or soon after ovulation?

• Does irritability last longer than sadness?

• Do symptoms lift on day one of bleeding, or continue for several days?

• Are there symptoms that remain present throughout the month and intensify premenstrually?

• Does a treatment, routine change, or stressful event shift your pattern?

Bring your HealCycle trend data to a gynaecologist, psychiatrist, psychologist, or reproductive mental-health professional. A clear record can support a more accurate PMDD assessment and a more personalised conversation about care.

When should you seek professional help?

Please seek professional support if premenstrual symptoms regularly affect your safety, relationships, work, studies, parenting, or ability to function. You do not need to wait until symptoms become a crisis to ask for help.

Seek urgent help immediately if you have:

• Suicidal thoughts, a plan, intent, or fear that you may act on thoughts of self-harm

• Severe agitation, loss of control, or inability to stay safe

• Symptoms of mania or psychosis

• Severe depression or anxiety that continues well beyond the menstrual phase

What should you take away from this research?

The strongest message is validating: PMDD is not one identical experience. Your pattern may start earlier, peak differently, involve particular symptoms, or resolve more slowly than someone else’s—and that difference is worth documenting and discussing.

Research has not yet created official PMDD subtype diagnoses or proven subtype-specific treatments. But it does offer a useful guide for the future: track precisely, assess the whole person, and move away from one-size-fits-all assumptions.

References

1. Eisenlohr-Moul TA, Kaiser G, Weise C, et al. Are there temporal subtypes of premenstrual dysphoric disorder?: Using group-based trajectory modeling to identify individual differences in symptom change. Psychological Medicine. 2020;50(6):964-972. doi:10.1017/S0033291719000849.

2. Wei S-M, Wakim P, Martinez PE, Nieman LK, Rubinow DR, Schmidt PJ. Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings. American Journal of Psychiatry. 2025;182(10):922-934. doi:10.1176/appi.ajp.20240596.

3. Eisenlohr-Moul TA. Toward Precision Reproductive Psychiatry: A Call for Targeted, Transdiagnostic Approaches to Premenstrual Disorders. American Journal of Psychiatry. 2025;182(10):894-897. doi:10.1176/appi.ajp.20250781.